Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON43057Phase 4Active, not recruiting
Phase 4, open-label trial of micafungin in candidiasis and mycoses (3 arms), sponsored by Radboud University Medical Center. Primary endpoints: Population pharmacokinetic model of micafungin, Model validation by bootstrap and 1 more. Started Jan 2017; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON43057.